Activation mechanism of the β2-adrenergic receptor
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
A third of marketed drugs act by binding to a G-protein-coupled receptor (GPCR) and either triggering or preventing receptor activation. Although recent crystal structures have provided snapshots of both active and inactive functional states of GPCRs, these structures do not reveal the mechanism by which GPCRs transition between these states. Here we propose an activation mechanism for the β2-adrenergic receptor, a prototypical GPCR, based on atomic-level simulations in which an agonist-bound receptor transitions spontaneously from the active to the inactive crystallographically observed conformation. A loosely coupled allosteric network, comprising three regions that can each switch individually between multiple distinct conformations, links small perturbations at the extracellular drug-binding site to large conformational changes at the intracellular G-protein-binding site. Our simulations also exhibit an intermediate that may represent a receptor conformation to which a G protein binds during activation, and suggest that the first structural changes during receptor activation often take place on the intracellular side of the receptor, far from the drug-binding site. By capturing this fundamental signaling process in atomic detail, our results may provide a foundation for the design of drugs that control receptor signaling more precisely by stabilizing specific receptor conformations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Crystal structure of opsin in its G-protein-interacting conformation
Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07330 · Cited by 1,059 · cited 1×
“Crystal structures of meta II (active) rhodopsin and of opsin (both with and without the Gα C-terminal helix bound) display a similar arrangement of helices 5, 6, and 7 (5, 21, 22), except that the intracellular end of helix 6 is shifted approximately 5 Å farther from the helical bundle in the active structure of β2AR…”
BackgroundCrystal structure of the ligand-free G-protein-coupled receptor opsin
Park, J. H., Scheerer, P., Hofmann, K. P., Choe, H.-W., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07063 · Cited by 903
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G. W., & Tate, C. G. (2011) · Nature · doi:10.1038/nature10136 · Cited by 873
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Structure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
Structure and function of an irreversible agonist-β2 adrenoceptor complex
Rosenbaum, D. M., Zhang, C., Lyons, J. A., Holl, R., Aragao, D., Arlow, D. H., Rasmussen, S. G. F., Choi, H.-J., DeVree, B. T., Sunahara, R. K., et al. (2011) · Nature · doi:10.1038/nature09665 · Cited by 767
Self-citationConformational complexity of G-protein-coupled receptors
Kobilka, B. K., & Deupi, X. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.003 · Cited by 694
Crystal structure of metarhodopsin II
Choe, H.-W., Kim, Y. J., Park, J. H., Morizumi, T., Pai, E. F., Krauß, N., Hofmann, K. P., Scheerer, P., & Ernst, O. P. (2011) · Nature · doi:10.1038/nature09789 · Cited by 663
KENT, R. S., DE LEAN, A., & LEFKOWITZ, R. J. (1980) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14062-5 · Cited by 553
Altenbach, C., Kusnetzow, A. K., Ernst, O. P., Hofmann, K. P., & Hubbell, W. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802515105 · Cited by 462
Measurement of the millisecond activation switch of G protein–coupled receptors in living cells
Vilardaga, J.-P., Bünemann, M., Krasel, C., Castro, M., & Lohse, M. J. (2003) · Nature Biotechnology · doi:10.1038/nbt838 · Cited by 431
β2 Adrenergic Receptor Activation
Shi, L., Liapakis, G., Xu, R., Guarnieri, F., Ballesteros, J. A., & Javitch, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206801200 · Cited by 422
MOLECULAR MECHANISM OF 7TM RECEPTOR ACTIVATION—A GLOBAL TOGGLE SWITCH MODEL
Schwartz, T. W., Frimurer, T. M., Holst, B., Rosenkilde, M. M., & Elling, C. E. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141218 · Cited by 408
Millisecond-scale molecular dynamics simulations on Anton
Shaw, D. E., Dror, R. O., Salmon, J. K., Grossman, J. P., Mackenzie, K. M., Bank, J. A., Young, C., Deneroff, M. M., Batson, B., Bowers, K. J., et al. (2009) · Proceedings of the Conference on High Performance Computing Networking, Storage and Analysis · doi:10.1145/1654059.1654099 · Cited by 382 · cited 4×
“We recently demonstrated the feasibility of such simulations (17), using specialized computer hardware that dramatically accelerates MD computations (18); that study included two simulations in which agonist-bound β2AR transitioned from an active to an inactive crystallographically observed conformation.”
BackgroundInfluentialSelf-citationGhanouni, P., Gryczynski, Z., Steenhuis, J. J., Lee, T. W., Farrens, D. L., Lakowicz, J. R., & Kobilka, B. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100162200 · Cited by 364
The evasive nature of drug efficacy: implications for drug discovery
Galandrin, S., Oligny-Longpré, G., & Bouvier, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.005 · Cited by 363
Ligand binding and micro-switches in 7TM receptor structures
Nygaard, R., Frimurer, T. M., Holst, B., Rosenkilde, M. M., & Schwartz, T. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.006 · Cited by 346
Sequential Binding of Agonists to the β2 Adrenoceptor
Swaminath, G., Xiang, Y., Lee, T. W., Steenhuis, J., Parnot, C., & Kobilka, B. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310888200 · Cited by 333
Dror, R. O., Arlow, D. H., Borhani, D. W., Jensen, M. Ø., Piana, S., & Shaw, D. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811065106 · Cited by 303
Self-citationMillisecond-scale molecular dynamics simulations on Anton
Shaw, D. E., Dror, R. O., Salmon, J. K., Grossman, J. P., Mackenzie, K. M., Bank, J. A., Young, C., Deneroff, M. M., Batson, B., Bowers, K. J., et al. (2009) · Proceedings of the Conference on High Performance Computing Networking, Storage and Analysis · doi:10.1145/1654059.1654126 · Cited by 294
Self-citationTracking G-protein-coupled receptor activation using genetically encoded infrared probes
Ye, S., Zaitseva, E., Caltabiano, G., Schertler, G. F. X., Sakmar, T. P., Deupi, X., & Vogel, R. (2010) · Nature · doi:10.1038/nature08948 · Cited by 263
Structure and Activation of the Visual Pigment Rhodopsin
Smith, S. O. (2010) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-101209-104901 · Cited by 192
Molecular Dynamics Investigation of Primary Photoinduced Eventsin the Activation of Rhodopsin
Saam, J., Tajkhorshid, E., Hayashi, S., & Schulten, K. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75314-9 · Cited by 168
Vogel, R., Mahalingam, M., Lüdeke, S., Huber, T., Siebert, F., & Sakmar, T. P. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.05.022 · Cited by 164
Internal Hydration Increases during Activation of the G-Protein-Coupled Receptor Rhodopsin
Grossfield, A. M., Pitman, M. C., Feller, S. E., Soubias, O., & Gawrisch, K. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.05.036 · Cited by 143
The Effect of pH on β2 Adrenoceptor Function
Ghanouni, P., Schambye, H. T., Seifert, R., Lee, T. W., Rasmussen, S. G. F., Gether, U., & Kobilka, B. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3121 · Cited by 132
Park, P. S.-H., Lodowski, D. T., & Palczewski, K. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094630 · Cited by 131 · cited 2×
“Although these experiments have not provided the same level of spatial and temporal detail as our simulations, rhodopsin activation involves similar conformational changes (5, 34) and also takes place via a set of intermediate states (35).”
BackgroundLiapakis, G., Chan, W. C., Papadokostaki, M., & Javitch, J. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1181 · Cited by 101
Rubenstein, R. C., Wong, S., & Ross, E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49305-2 · Cited by 88
Highly conserved tyrosine stabilizes the active state of rhodopsin
Goncalves, J. A., South, K., Ahuja, S., Zaitseva, E., Opefi, C. A., Eilers, M., Vogel, R., Reeves, P. J., & Smith, S. O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009405107 · Cited by 80
Putative Active States of a Prototypic G-Protein-Coupled Receptor from Biased Molecular Dynamics
Provasi, D., & Filizola, M. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.01.047 · Cited by 70
A conserved protonation-induced switch can trigger "ionic-lock" formation in adrenergic receptors.
Vanni, S., Neri, M., Tavernelli, I., & Rothlisberger, U. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.060 · Cited by 38
Atomistic Insights into Rhodopsin Activation from a Dynamic Model
Tikhonova, I. G., Best, R. B., Engel, S., Gershengorn, M. C., Hummer, G., & Costanzi, S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0765520 · Cited by 37
Mechanism of G‐protein Activation by Rhodopsin†
Shichida, Y., & Morizumi, T. (2007) · Photochemistry and Photobiology · doi:10.1562/2006-03-22-ir-854 · Cited by 30 · cited 1×
“Indeed, spectroscopic studies of rhodopsin have suggested a two-step interaction mechanism in which GDP-bound transducin first forms a complex with an intermediate conformation of rhodopsin, and subsequently the two undergo a conformational change resulting in the fully active receptor conformation and GDP release fro…”
Background
Cited by
Molecular Dynamics Simulation for All
Hollingsworth, S. A., & Dror, R. O. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.011 · Cited by 3,257
Self-citationMolecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
The Molecular Basis of G Protein–Coupled Receptor Activation
Weis, W. I., & Kobilka, B. K. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033910 · Cited by 1,227
“An intermediate that resembles the agonist-bound intermediate of the A2aR is seen in these simulations (46).”
BackgroundBiomolecular Simulation: A Computational Microscope for Molecular Biology
Dror, R. O., Dirks, R. M., Grossman, J. P., Xu, H., & Shaw, D. E. (2012) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-042910-155245 · Cited by 1,198
Self-citationWater Determines the Structure and Dynamics of Proteins
Bellissent-Funel, M.-C., Hassanali, A., Havenith, M., Henchman, R., Pohl, P., Sterpone, F., van der Spoel, D., Xu, Y., & Garcia, A. E. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00664 · Cited by 945
Metadata
- Authors
- Dror, R. O., Arlow, D. H., Maragakis, P., Mildorf, T. J., Pan, A. C., Xu, H., Borhani, D. W., & Shaw, D. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2011-10-26
- Volume
- 108
- Issue
- 46
- Pages
- 18684-18689
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1997340548
- Cited by
- 623
- References
- 41
- FWCI
- 11.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.